Lerer Kenneth B's Form 4 filing
Strata Critical Medical, Inc. (SRTA) · filed Jun 2, 2022
- Accession no.
- 0000899243-22-020767
- Filed
- Jun 2, 2022
- Trade date
- May 31-Jun 2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $2.05M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lerer Kenneth BCIK 0001120789 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 31, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −30,989 | $7.06F1 | −$218,782.34 | 467,123 | Indirect | |
| May 31, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −16,582 | $7.06F1 | −$117,068.92 | 249,962 | Indirect | |
| Jun 1, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −1,297 | $7.01F5 | −$9,091.97 | 465,826 | Indirect | |
| Jun 1, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −694 | $7.01F5 | −$4,864.94 | 249,268 | Indirect | |
| Jun 2, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −150,961 | $7.34F6 | −$1,108,053.74 | 314,865 | Indirect | |
| Jun 2, 2022 | Class A common stock, $0.0001 par value per share | SSaleDisposed | −80,780 | $7.34F6 | −$592,925.2 | 168,488 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These transactions were executed in multiple trades at prices ranging from $7.00 to $7.18, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 2 transactions in Table I.
- F5
These transactions were executed in multiple trades at prices ranging from $7.000 to $7.045, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 2 transactions in Table I.
- F6
These transactions were executed in multiple trades at prices ranging from $7.03 to $7.45, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC, the Issuer, or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 2 transactions in Table I.